Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2018-00533 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| 9831 | Other Identifier | Fred Hutch/University of Washington Cancer Consortium | |
| RG1001545 | Other Identifier | Fred Hutch/University of Washington Cancer Consortium | |
| 5P50CA097186-17 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Study closed to accrual before meeting enrollment goal due to end of funding.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.
OUTLINE:
Participants receive web-based or hard-copy questionnaires and saliva collection kits via mail or in person. Participants also provide saliva samples to be mailed back to Color Genomics for genetic testing once complete. Participants then receive phone-based genetic counseling if they are identified to have an inherited mutation in a deoxyribonucleic acid (DNA) repair gene. All participants have access to phone-based genetic counseling whether or not they are not found to have a mutation.
After study completion, participants are followed up at 6 months.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ancillary-Correlative (questionnaires, Color kit, counseling) | Participants receive web-based or hard-copy questionnaires and saliva collection kits via mail or in person. Participants also provide saliva samples to be mailed back to Color Genomics for genetic testing once complete. Participants then receive phone-based genetic counseling if they are identified to have an inherited mutation in a DNA repair gene. All participants have access to phone-based genetic counseling whether or not they are not found to have a mutation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Biospecimen Collection | Procedure | Provide saliva samples |
|
| Measure | Description | Time Frame |
|---|---|---|
| Frequency of pathogenic germline homologous recombination (HR) variants in men with metastatic prostate cancer (mPC) | Frequency to be determined by genetic testing on saliva samples for inherited mutations in cancer risk genes such as BRCA2, BRCA1, ATM, and others in metastatic prostate cancer. | From the start of study up to 3 years |
| Patient reported outcome measures associated with genetic testing in men with mPC | Outcome measures to be defined by patient reported outcomes questionnaire (on-line or hard copy) at enrollment, and at 6-month follow-up. | From the time of enrollment up to 6-month follow-up |
| Utility of family history to enrich screening of participants with mPC for germline homologous recombination deficiency (HRD) variants defined by collection of information about research participants' family history | To be determined by collection of information about research participants' family history that includes cancer history (diagnosis, age of onset, treatment, etc.) but will not include identifiers of family members. This information will be used to examine which self-reported family history criteria may be associated with identification of cancer predisposition syndrome. | From the start of study up to 3 years |
| Identification of a cohort of men with prostate cancer and inherited HRD mutations | Identification to be determined through the Washington state cancer registry, through mail-out to all urologists and medical oncologists in the state of Washington, and through the Seattle Cancer Care Alliance Network sites. In addition, web-based advertising and recruiting will occur more broadly through the U.S., including at partnering sites. | From the start of study up to 3 years |
Not provided
Not provided
Inclusion Criteria:
Signed informed consent form (ICF) providing agreement for germline genetic testing, use and release of health and research trial information
Documented evidence of metastatic prostate cancer;
Willingness to provide basic demographic information, family cancer history, and treatment history
Willingness and ability to complete patient reported outcomes questionnaire (on-line or hard copy) at enrollment, and at 6-month follow-up
Willingness and ability to provide saliva sample
Exclusion Criteria:
Not provided
Not provided
Not provided
Participants with metastatic prostate cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Heather H. Cheng | Fred Hutch/University of Washington Cancer Consortium | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | United States |
Not provided
| ID | Term |
|---|---|
| D011471 | Prostatic Neoplasms |
| D009362 | Neoplasm Metastasis |
| ID | Term |
|---|---|
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
| ID | Term |
|---|---|
| D005817 | Genetic Counseling |
| D005820 | Genetic Testing |
| D011795 | Surveys and Questionnaires |
| ID | Term |
|---|---|
| D033142 | Genetic Services |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
| D019411 | Clinical Laboratory Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Saliva
| Genetic Counseling | Other | Undergo counseling |
|
| Genetic Testing | Other | Undergo genetic testing |
|
|
| Laboratory Biomarker Analysis | Other | Correlative studies |
|
| Questionnaire | Behavioral | Complete questionnaire |
|
|
| D005832 |
| Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |
| D009385 | Neoplastic Processes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
| D005821 | Genetic Techniques |
| D003954 | Diagnostic Services |
| D011314 | Preventive Health Services |
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |